Gilead Sciences (GILD) Leases (2019 - 2024)
Historic Leases for Gilead Sciences (GILD) over the last 9 years, with Q4 2024 value amounting to $515.0 million.
- Gilead Sciences' Leases fell 1135.97% to $515.0 million in Q4 2024 from the same period last year, while for Dec 2024 it was $515.0 million, marking a year-over-year decrease of 1135.97%. This contributed to the annual value of $515.0 million for FY2024, which is 1135.97% down from last year.
- Gilead Sciences' Leases amounted to $515.0 million in Q4 2024, which was down 1135.97% from $581.0 million recorded in Q4 2023.
- In the past 5 years, Gilead Sciences' Leases ranged from a high of $646.0 million in Q4 2020 and a low of $505.0 million during Q4 2022
- For the 5-year period, Gilead Sciences' Leases averaged around $557.8 million, with its median value being $542.0 million (2021).
- Its Leases has fluctuated over the past 5 years, first crashed by 1609.91% in 2021, then skyrocketed by 1504.95% in 2023.
- Quarter analysis of 5 years shows Gilead Sciences' Leases stood at $646.0 million in 2020, then fell by 16.1% to $542.0 million in 2021, then decreased by 6.83% to $505.0 million in 2022, then increased by 15.05% to $581.0 million in 2023, then dropped by 11.36% to $515.0 million in 2024.
- Its last three reported values are $515.0 million in Q4 2024, $581.0 million for Q4 2023, and $505.0 million during Q4 2022.